Disease, Microbiology, Biotechnology, Epidemiology, Infectious disease, Medicine
STAT+ Conversations: A conversation with vaccine expert Paul Offit
RT @statnews: IN ONE HOUR
@matthewherper leads our next STAT Plus Conversation: with vaccine expert Paul Offit.
Be part of the conversation here: https://t.co/zYrMezluwQ
Watch the live stream here: https://t.co/8WY36qR1K9
OpenSTAT's Matthew Herper sits down with vaccine expert Paul Offit to discuss the ongoing Covid-19 vaccine rollout.
RT @statnews: IN ONE HOUR
@matthewherper leads our next STAT Plus Conversation: with vaccine expert Paul Offit.
Be part of the conversation here: https://t.co/zYrMezluwQ
Watch the live stream here: https://t.co/8WY36qR1K9
OpenSTAT+ Conversations: A conversation with vaccine expert Paul Offit
STAT's Matthew Herper sits down with vaccine expert Paul Offit to discuss the ongoing Covid-19 vaccine rollout.
We are sorry, we could not find the related article
If you are curious about Biotech Essentials, the Influencers Review and Companies & Industries
Please click on:
Or signup to our newsletters
COVID-19 vaccine trial by Moderna shows positive early results
(Xinhua) "We are investing to scale up manufacturing so we can maximize the number of doses we can produce to help protect as many people as we can from SARS-CoV-2." WASHINGTON, May 18 ...
BIOEquality, data sharing and deals: a BioCentury podcast
BIO is calling on biopharmaceutical companies to put their pledges on social justice into practice as the trade group launches an initiative that aims to diversify the biotech workforce and ...
4 takeaways from FDA's Covid-19 vaccine meeting
While there is no specific vaccine on the table yet, the committee is hearing from federal agencies and vaccine makers about their efforts to prove a shot is both safe and effective.
As a new Covid-19 treatment arrives, hospitals scramble to solve logistical and ethical challenges
Hospitals need to find space and staff to administer the drug at a time when there’s hardly enough of either to treat those who are sick.
Coming soon: A breathalyzer to detect malaria?
A Washington University researcher has pinpointed six biomarkers that could lead to a simple breathalyzer test for malaria.
Data, data and more data will make a coronavirus vaccine safe, USA TODAY's vaccine panel says
USA TODAY's expert panel sees steady progress toward a safe and effective COVID vaccine, urge public's patience as trials proceed and data comes in.
American Doctors Are Treating a Coronavirus Patient With a Robot
The goal is to nip an American outbreak in the bud.
Responding to COVID-19: A Science-Based Approach
Brought to you by the American Public Health Association and the National Academy of Medicine, this webinar series will explore the state of the science surrounding the current outbreak of ...
WuXi Biologics Enables Development of Multiple Neutralizing Antibodies for Novel Coronavirus
/PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a leading global open-access biologics technology platform company offering end-to-end solutions for...
DEINOVE to collaborate with CALIBR to explore broadly the anti-infectious potentials of its bacterial collection
CALIBR is a division of the Scripps Research, a California non-profit corporation, dedicated to finding new treatments addre
Director, Integrated Research Facility
Division of Clinical Research POC: [email protected] Open: February 18-27, 2019
Combating infectious diseases with next-generation sequencing
Infectious disease physician and clinical microbiologist Charles Chiu is the director of the Abbott Viral Diagnostics and Discovery Center at the University of California, San Francisco. ...
COVID-19 & the Latinx Community
Through this forum, Hispanic scientists and doctors from Yale University will share their roles investigating the new coronavirus and treating patients with the COVID-19 disease and will ...
BIO Annual Meeting Goes Digital with Focus on COVID-19
This year’s event, which kicks off June 8, will have a different look as an entirely digital conference.